Bone Biologics Stock Forecast

Buy or Hold candidate since Jun 16, 2026 Gain 5.80%

The Bone Biologics Corporation stock price fell by -0.680% on the last day (Thursday, 18th Jun 2026) from $1.47 to $1.46. During the last trading day the stock fluctuated 11.68% from a day low at $1.37 to a day high of $1.53. The price has been going up and down for this period, and there has been a 16.8% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -944 thousand shares and in total, 463 thousand shares were bought and sold for approximately $675.44 thousand.

The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.47 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 10.30% during the next 3 months and, with a 90% probability hold a price between $1.33 and $1.62 at the end of this 3-month period.

BBLG Signals & Forecast

The Bone Biologics Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.36 and $1.29. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 17, 2026, and so far it has fallen -0.680%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Bone Biologics Corporation stock

Bone Biologics Corporation finds support from accumulated volume at $1.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.160 between high and low, or 11.68%. For the last week the stock has had daily average volatility of 10.98%.

Our recommended stop-loss: $1.40 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (BBLG) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Bone Biologics Corporation to open at $1.45, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.50, which gives a possible trading interval of +/-$0.0866 (+/-6.11%) up or down from last closing price. If Bone Biologics Corporation takes out the full calculated possible swing range there will be an estimated 6.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.47 (0.68%) than the support at $1.44 (1.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Bone Biologics Corporation stock A Buy?

Bone Biologics Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.

Current score: 0.613 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $1.45 ( 0.457%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk